Research involving AHK-Cu copper peptide has examined its effects on collagen synthesis, fibroblast activity, and dermal matrix support in preclinical models
Certain therapies discussed may be investigational and are not approved by the FDA for the diagnosis, treatment, cure, or prevention of disease
The research peptide vendor closed 2026 narrative reaches its peak, with three major suppliers exiting within a nine-month window
Ashley et al., 2012
Coenzyme cellular energy IV/SubQ 100500 mg Mitochondrial-derived peptide preclinical 35x weekly 510 mg Mitochondrial-derived peptide preclinical no approved human dose Mitochondria-targeting peptide FDA-approved only for Barth syndrome daily 440 mg AEDG tetrapeptide bioregulator research-use 1020 day cycles Senolytic peptide preclinical only no validated human dose Endogenous antioxidant oral/liposomal/IV context 2501,000 mg oral study range MC receptor agonist preclinical loading + maintenance 250500 mcg Also listed under Repair skin remodeling topical/SubQ 12 mg Sexual Health & Hormonal Peptides studied for sexual response and hormonal pathways
Also valuable for patients with chronic gut infections where immune surveillance needs a boost recurring SIBO, candida overgrowth, or parasitic infections that keep coming back
